IPS UMBRELLA MEDICAL LIMITEDActive

Company number 06969141Private limited companyIncorporated 2009
⚠ Accounts overdue. The next accounts were due on 30 Sep 2026 and had not been filed when the register was last updated.
⚠ Confirmation statement overdue. It was due on 5 Aug 2026.

Key figures

£28,387+0.0%
Net assets 2024
+0.0%
Average annual growth 2020–2024
010 k20 k30 k20202021202220232024

Like most small UK companies, IPS UMBRELLA MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k20202021202220232024
Filed accounts2020–2024
20202021202220232024
Cash at bank and in hand6,1456,0516,0516,0516,051
Total assets22,43628,38726,38728,38728,387
Total liabilities5,951————
Net assets / total equity28,38728,38726,38728,38728,387
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: IPS UMBRELLA MEDICAL LIMITED

Company

IPS UMBRELLA MEDICAL LIMITED is a private limited company registered with Companies House under company number 06969141. It was incorporated on 22 Jul 2009. Its status is active. The registered office is in Liverpool (L24). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts (filleted). Net assets were £28,387, up 0% on the previous year. Cash at bank and in hand was £6,051. The company had an average of 0 employees. Figures are available for 5 financial years (2020–2024).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 5 Aug 2026.